These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33912076)

  • 1. Role of Podoplanin-Positive Cells in Cardiac Fibrosis and Angiogenesis After Ischemia.
    Cimini M; Kishore R
    Front Physiol; 2021; 12():667278. PubMed ID: 33912076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction.
    Cimini M; Garikipati VNS; de Lucia C; Cheng Z; Wang C; Truongcao MM; Lucchese AM; Roy R; Benedict C; Goukassian DA; Koch WJ; Kishore R
    JCI Insight; 2019 Jul; 5(15):. PubMed ID: 31287805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.
    Cimini M; Cannatá A; Pasquinelli G; Rota M; Goichberg P
    PLoS One; 2017; 12(3):e0173927. PubMed ID: 28333941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin Positive Cell-derived Extracellular Vesicles Contribute to Cardiac Amyloidosis After Myocardial Infarction.
    Cimini M; Hansmann UHE; Gonzalez C; Chesney AD; Truongcao MM; Gao E; Wang T; Roy R; Forte E; Mallaredy V; Thej C; Magadum A; Joladarashi D; Benedict C; Koch WJ; Tükel Ç; Kishore R
    bioRxiv; 2024 Jul; ():. PubMed ID: 39005419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the CLEC-2-podoplanin interaction in tumor progression.
    Suzuki-Inoue K
    Platelets; 2018 Jun; ():1-7. PubMed ID: 29863945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin in Inflammation and Cancer.
    Quintanilla M; Montero-Montero L; Renart J; Martín-Villar E
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New horizon in platelet function: with special reference to a recently-found molecule, CLEC-2.
    Ozaki Y; Tamura S; Suzuki-Inoue K
    Thromb J; 2016; 14(Suppl 1):27. PubMed ID: 27766053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
    Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
    J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin: A potential therapeutic target for thrombotic diseases.
    Huang Y; Lu M; Wang Y; Zhang C; Cao Y; Zhang X
    Front Neurol; 2023; 14():1118843. PubMed ID: 36970507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor podoplanin: from discovery to drug development.
    Takemoto A; Miyata K; Fujita N
    Cancer Metastasis Rev; 2017 Jun; 36(2):225-234. PubMed ID: 28674748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet C-Type Lectin-Like Receptor 2 Reduces Cholestatic Liver Injury in Mice.
    Maruyama S; Kono H; Furuya S; Shimizu H; Saito R; Shoda K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Shirai T; Suzuki-Inoue K; Ichikawa D
    Am J Pathol; 2020 Sep; 190(9):1833-1842. PubMed ID: 32473917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic blood filling in CLEC-2-deficient mouse models.
    Haining EJ; Lowe KL; Wichaiyo S; Kataru RP; Nagy Z; Kavanagh DP; Lax S; Di Y; Nieswandt B; Ho-Tin-Noé B; Mehrara BJ; Senis YA; Rayes J; Watson SP
    Platelets; 2021 Apr; 32(3):352-367. PubMed ID: 32129691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
    Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podoplanin: Its roles and functions in neurological diseases and brain cancers.
    Wang Y; Peng D; Huang Y; Cao Y; Li H; Zhang X
    Front Pharmacol; 2022; 13():964973. PubMed ID: 36176432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin: emerging functions in development, the immune system, and cancer.
    Astarita JL; Acton SE; Turley SJ
    Front Immunol; 2012; 3():283. PubMed ID: 22988448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2.
    Ogasawara S; Kaneko MK; Price JE; Kato Y
    Hybridoma (Larchmt); 2008 Aug; 27(4):259-67. PubMed ID: 18707544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets Regulate the Migration of Keratinocytes via Podoplanin/CLEC-2 Signaling during Cutaneous Wound Healing in Mice.
    Asai J; Hirakawa S; Sakabe J; Kishida T; Wada M; Nakamura N; Takenaka H; Mazda O; Urano T; Suzuki-Inoue K; Tokura Y; Katoh N
    Am J Pathol; 2016 Jan; 186(1):101-8. PubMed ID: 26597882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CLEC-2 induced signalling in blood platelets].
    Martyanov AA; Kaneva VN; Panteleev MA; Sveshnikova AN
    Biomed Khim; 2018 Sep; 64(5):387-396. PubMed ID: 30378555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.